- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
FDA Launches AccessGUDID, a Database to Track Devices
The database will allow consumers, healthcare providers, and product manufacturers to access information tracked on medical devices, with the end goal of improving patient safety, improving device postmarket surveillance, and facilitating medical device innovation.
The FDA launched an eagerly-anticipated database to allow consumers, healthcare providers and product manufacturers to access information tracked on medical devices.
The online Global Unique Device Identification Database, called AccessGUDID, follows almost 3 years after Congress mandated that medical devices be marked and tracked with unique identifiers. FDA’s database uses a unique device identification system to identify devices sold in the US, with the capability to track them from manufacturing through distribution to patient use, the FDA said.
When fully implemented, the label of most devices will include a UDI in human- and machine-readable form. Device labelers must also submit certain information about each device to AccessGUDID, where the public can search and download information.
Read the article on Governement HealthIT: http://bit.ly/1ctcAlM
STEER Data Open Door to SMA Gene Therapy for Wider Age Range of Children
March 19th 2025Delivery of onasemnogene abeparvovec into the intrathecal space was safe and effective for children with spinal muscular atrophy (SMA) aged 2 to 17 years, who had previously been shut out of receiving gene therapy.
Read More
Bustling Gene Therapy Pipeline for Neuromuscular Diseases Brings Thorny Questions to the Clinic
March 18th 2025The rapid development of gene therapy options for treating neuromuscular diseases has created new therapeutic options but also logistical hurdles and a need for complex discussions between clinicians and families.
Read More
